PCP
IDXX icon

Perimeter Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Perimeter Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-7,744
Closed -$347K – 249
2013
Q2 		$347K Buy
+7,744
New +$338K 0.07% 190

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Perimeter Capital Partners's IDXX Position: Q3 2013 in Review

Perimeter Capital Partners sold out of Idexx Laboratories (IDXX) in Q3 2013, closing a stake of 7,744 shares — an estimated $347K sold.

Perimeter Capital Partners first reported a position in IDXX in Q2 2013 and held it in 1 quarter. The position peaked at $347K in Q2 2013. 274 funds tracked by Wall St. Rank hold IDXX as of Q3 2013.

  • Perimeter Capital Partners reported no remaining Idexx Laboratories position as of Q3 2013 after selling out during the quarter.
  • Perimeter Capital Partners sold 7,744 Idexx Laboratories shares in Q3 2013, an estimated $347K.
  • Perimeter Capital Partners first reported a position in Idexx Laboratories in Q2 2013 and held it in 1 quarter.
  • Perimeter Capital Partners's Idexx Laboratories position peaked at $347K in Q2 2013.
  • 274 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2013.

Based on Perimeter Capital Partners's 13F filing for Q3 2013, filed 14 Nov 2013.